AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $81,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cypress Capital Management LLC (WY) | 234,225 | $132,000 | 0.18% |
| Noven Financial Group, Inc. | 123,772 | $70,000 | 0.04% |
| Harvest Investment Services, LLC | 109,443 | $60,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 559,489 | $314,000 | 0.03% |
| COURIER CAPITAL LLC | 354,973 | $199,000 | 0.03% |
| Valeo Financial Advisors, LLC | 330,000 | $185,000 | 0.02% |
| Transform Wealth, LLC | 205,481 | $115,000 | 0.02% |
| WEDBUSH SECURITIES INC | 326,793 | $184,000 | 0.02% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 55,500 | $31,000 | 0.02% |
| MONTAG A & ASSOCIATES INC | 230,000 | $129,000 | 0.01% |